- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on NTRK1 Fusion Positive in New Zealand
Total 952 results
-
HI-BioCompletedGlomerulonephritis | Membranous Nephropathy | antiPLA2R PositiveTaiwan, Korea, Republic of, Greece, Germany, United Kingdom, Georgia, Russian Federation
-
Teva Branded Pharmaceutical Products R&D, Inc.Cephalon; ChemGenex PharmaceuticalsCompletedChronic Myeloid LeukemiaUnited States, Canada, France, Germany, Hungary, India, Italy, Poland, Singapore, United Kingdom
-
Astellas Pharma Europe B.V.Merck Sharp & Dohme LLCCompletedClostridium Difficile-associated Diarrhea (CDAD)United States, Belgium, Italy, Canada, France, Germany, Hungary, Poland, Romania, Spain
-
Janssen Infectious Diseases BVBAWithdrawnMulti-drug Resistant TuberculosisChina, Ukraine, Taiwan, Korea, Republic of, Peru, Brazil, Estonia, Latvia, Philippines, Russian Federation, South Africa, Thailand, Turkey, Georgia, Mexico, Cambodia, Ethiopia
-
Novartis PharmaceuticalsRecruitingChronic Myelogenous Leukemia - Chronic PhaseUnited States
-
Reveal Pharmaceuticals Inc.National Cancer Institute (NCI)RecruitingMultiple Sclerosis | Brain Neoplasms | Brain Cancer | Brain Tumor | Neurofibroma | Brain Tumors | Brain Metastases | Brain Tumor, Recurrent | CNS Tumor | Acoustic Neuroma | CNS Cancer | CNS Lymphoma | Brain Neoplasms, Benign | Brain Tumor, Primary | CNS Metastases | CNS Lesion | Multiple Sclerosis Brain Lesion | Brain Neoplasm... and other conditionsUnited States
-
Vedanta Biosciences, Inc.CompletedClostridium Difficile Infection | Clostridium Difficile Infection Recurrence | Clostridium Difficile | CDI | Clostridioides Difficile Infection | Clostridioides Difficile | Clostridioides Difficile Infection RecurrenceUnited States, Canada
-
Yale UniversityNational Institute on Drug Abuse (NIDA); Baystate Medical CenterCompletedHIV | Opioid Dependence | AIDS | Drug DependenceUnited States
-
ContraFectTerminatedStaphylococcus Aureus Bacteremia | Staphylococcus Aureus EndocarditisUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingChemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerRecurrent Breast Carcinoma | HER2/Neu Positive | Progesterone Receptor Positive | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States, Canada, Puerto Rico, Ireland
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingBreast Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast Carcinoma | HER2-Negative Breast CarcinomaUnited States
-
Cubist Pharmaceuticals LLCCompletedStaphylococcal Skin InfectionsUnited States, Puerto Rico
-
Cadila PharnmaceuticalsTerminatedHormone Refractory Prostate CancerIndia
-
ContraFectCompletedStaphylococcus Aureus Bacteremia | Staphylococcus Aureus EndocarditisUnited States, Belgium, Bulgaria, Chile, Czechia, France, Germany, Greece, Guatemala, Israel, Italy, Russian Federation, Spain, United Kingdom
-
Rebiotix Inc.CompletedEnterocolitis Clostridium Difficile RecurrentUnited States, Canada
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | Mycobacterium Avium-intracellulare InfectionUnited States
-
Novartis PharmaceuticalsRecruitingPhiladelphia Chromosome-Positive Chronic Myeloid LeukemiaGermany, United Arab Emirates, Greece, Czechia, Hungary, United States, Oman, Malaysia, France, Turkey, Bulgaria, Canada, Slovakia, Argentina, Italy, Jordan, Romania, South Africa, Korea, Republic of, Singapore, United Kingdom, Sw... and more
-
PharmaciaCompletedHIV Infections | Mycobacterium Avium-Intracellulare InfectionUnited States
-
PharmaciaCompletedHIV Infections | Mycobacterium Avium-intracellulare InfectionUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | Mycobacterium Avium-intracellulare InfectionUnited States
-
GlaxoSmithKlineCompletedTetanus | Diphtheria | Acellular PertussisUnited States
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaUnited States, Canada
-
CytomX TherapeuticsCompletedNeoplasms | Breast Cancer | Breast Neoplasms | Breast Neoplasms, Triple-Negative | Breast Neoplasms, Hormone Receptor Positive/HER2 NegativeUnited States, Spain, Korea, Republic of
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaCanada, Egypt, Saudi Arabia, Australia, Lebanon, South Africa, Israel, Russian Federation, Brazil, Thailand, Malaysia, Argentina, Taiwan, India, Oman, United Arab Emirates, Tunisia, Mexico, Algeria
-
Seagen Inc.RemeGen Co., Ltd.RecruitingStomach Neoplasms | Breast Neoplasms | Triple Negative Breast Neoplasms | Gastroesophageal Junction Adenocarcinoma | HER2 Positive Breast Neoplasms | HER2 Low Breast NeoplasmsUnited States, Canada
-
University of ColognePfizerCompletedStaphylococcus Aureus | Wound Infection, Surgical | EpidemiologyGermany, Spain, France, Italy, United Kingdom
-
PfizerCompletedSkin/Soft Tissue Infections | Methicillin Resistant Staphylococcus Aureus (MRSA)United States, Spain, United Kingdom, Colombia, Italy, Chile, Argentina, Mexico, Belgium, Russian Federation, Brazil, Malaysia, Singapore, Portugal, South Africa, Venezuela
-
AstraZenecaActive, not recruitingCervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 PositiveUnited States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore
-
AstraZenecaActive, not recruitingER-Positive HER2-Negative Breast CancerAustria, Belgium, France, Germany, Italy, United Kingdom, United States, Canada, India, Taiwan, Russian Federation, Korea, Republic of, Hungary, Japan, Mexico, Turkey, China, Malaysia, Spain, Czechia, Portugal, Poland, Norway, Bulgaria, Slovaki... and more
-
AbbVieCompletedBacterial Infections | Staphylococcal Skin Infections | Methicillin-Resistant Staphylococcus AureusUnited States, Bulgaria, Chile, Colombia, Georgia, Greece, Guatemala, Latvia, Mexico, Panama, Spain, Ukraine
-
Northwestern UniversityNational Cancer Institute (NCI); BHR Pharma, LLCRecruitingEstrogen Receptor Positive | Ductal Breast Carcinoma In SituUnited States
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous Leukemia - Chronic PhaseUnited States
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingHIV Infections | TuberculosisUnited States, Malawi, Puerto Rico, South Africa, Thailand, Zimbabwe, Brazil, Kenya, Uganda, India, Tanzania, Botswana
-
Insmed IncorporatedNational Institute of Allergy and Infectious Diseases (NIAID)CompletedMycobacterium Infections, NontuberculousUnited States, Canada
-
Hoffmann-La RocheTerminatedEstrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast CancerCanada, United States, United Kingdom, Australia, Germany
-
GlaxoSmithKlineCompletedHepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type bIndia
-
National Cancer Institute (NCI)CompletedHIV Infection | Recurrent Grade 3 Follicular Lymphoma | Plasmablastic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Primary Effusion Lymphoma | AIDS-Related Primary Effusion Lymphoma | Ann Arbor Stage I Diffuse Large B-Cell Lymphoma | Ann Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor... and other conditionsUnited States
-
Summit TherapeuticsCompletedClostridioides Difficile InfectionUnited States, Spain, France, Canada, Belgium, Israel, Chile, Belarus, Latvia, Germany, Romania, Lithuania, Mexico, Czechia, Estonia, Georgia, Peru
-
Centers for Disease Control and PreventionTuberculosis Trials ConsortiumRecruitingTuberculosis, Pulmonary | Tuberculosis InfectionCanada, United States, Haiti, South Africa, Uganda, Vietnam
-
GlaxoSmithKlineCompletedTetanus | Diphtheria | Acellular PertussisUnited States
-
PfizerCompletedChronic Myeloid LeukemiaUnited States, Canada, Spain, China, Australia, Singapore, Korea, Republic of, France, Hong Kong, Netherlands, Turkey, Poland, Japan, United Kingdom, Argentina, Colombia, Hungary, Russian Federation, South Africa, Belgium, Brazil, Chil... and more
-
Armata Pharmaceuticals, Inc.United States Department of DefenseRecruitingBacteremia | Staphylococcus Aureus | Staphylococcus Aureus Bacteremia | Bacteremia Due to Staphylococcus Aureus | Bacteremia StaphUnited States, Australia
-
Novartis PharmaceuticalsCompletedCHRONIC MYELOGENOUS LEUKEMIACanada, Australia, Spain, Argentina, France, Brazil
-
GlaxoSmithKlineAffinivax, Inc.RecruitingPneumococcal Infections | Pneumonia, Pneumococcal | Pneumonia, BacterialUnited States, Puerto Rico
-
Sunesis PharmaceuticalsCompletedMyelodysplastic Syndromes | Leukemia, Lymphocytic, Acute | Leukemia, Myeloid, Chronic | Leukemia, Nonlymphocytic, AcuteUnited States
-
BioMérieuxCompletedActive Tuberculosis | Latent Tuberculosis Infection | Non-Tuberculous Mycobacterial (NTM) PneumoniaUnited States, France, United Kingdom, India, Brazil, Georgia, Italy, Mexico, South Africa
-
Merck Sharp & Dohme LLCCompletedClostridium Difficile InfectionUnited States, Argentina, Brazil, Colombia, Czechia, Germany, Hungary, Malaysia, Mexico, Norway, Poland, Portugal, Romania, South Africa, Spain, Sweden, United Kingdom
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
Global Alliance for TB Drug DevelopmentSanofi; University College, London; European and Developing Countries Clinical... and other collaboratorsCompletedPulmonary TuberculosisChina, Zambia, Tanzania, India, Kenya, Malaysia, Mexico, South Africa, Thailand
-
Synta Pharmaceuticals Corp.CompletedBreast Cancer | Triple Negative Breast Cancer | HER-2 Positive Breast Cancer | ER/Progressive Response (PR) + Refractory to Prior Hormonal TreatmentSpain, United States, Argentina, Belgium, Brazil, Korea, Republic of, Peru, United Kingdom